Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease non-alcoholic fatty liver disease
Symptom C0948265|metabolic syndrome
Sentences 18
PubMedID- 25911912 The aim of the study was to evaluate the main features of the gastrointestinal myoelectrical activity (gi mea) in patients with nonalcoholic fatty liver disease (nafld) associated with metabolic syndrome (ms).
PubMedID- 21789263 The incidence of hepatocellular carcinoma (hcc) has risen as a result of increased global burden of chronic liver disease due to hepatitis b and c virus infections, aflatoxin b1, alcoholism, and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis associated with the metabolic syndrome.
PubMedID- 26308292 Context: an excess circulating uric acid level, even within the normal range, is always comorbid with metabolic syndrome (ms), several of its components, and nonalcoholic fatty liver disease (nafld), which was regarded as hepatic manifestation of ms; however, these associations remain controversial.
PubMedID- 21040936 The metabolic syndrome is associated with nonalcoholic fatty liver disease (nafld) as well as with insulin resistance, inflammatory adipokines, endothelial dysfunction, and higher plasma levels of nonesterified fatty acids (nefa), all of which may also affect the development of nafld.
PubMedID- 22813407 Association of nonalcoholic fatty liver disease with metabolic syndrome in indian population.
PubMedID- 23032980 Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in korean adults.
PubMedID- 26399788 nonalcoholic fatty liver disease is associated with metabolic syndrome and has the unique characteristic of excess lipid accumulation in liver.
PubMedID- 22546752 Gamma-glutamyl transferase: a marker of nonalcoholic fatty liver disease in patients with the metabolic syndrome.
PubMedID- 24850609 Effect of gene polymorphism of ppargamma2 regulatory proteins on the metabolic syndrome in children with nonalcoholic fatty liver disease and obesity.
PubMedID- 22844333 nonalcoholic fatty liver disease is associated with metabolic syndrome.
PubMedID- 19880582 Accumulating trans-sectional evidence suggests that the presence of multiple metabolic disorders, including obesity, diabetes, dyslipidemia, hypertension, and ultimately metabolic syndrome, are associated with nonalcoholic fatty liver disease (nafld) (1).
PubMedID- 24665369 found that serum zag concentrations were the only independent predictor of the number of metabolic syndrome components in patients with nonalcoholic fatty liver disease (nafld) after stepwise linear regression analysis.
PubMedID- 24044566 Serum adiponectin, leptin, resistin and rbp4 levels in obese and metabolic syndrome children with nonalcoholic fatty liver disease.
PubMedID- 22808787 The aim of review: to verify the role of nutrition in development of nonalcoholic fatty liver disease in patients with metabolic syndrome.
PubMedID- 26120587 nonalcoholic fatty liver disease relationship with metabolic syndrome in class iii obesity individuals.
PubMedID- 21212755 nonalcoholic fatty liver disease is associated with the metabolic syndrome.
PubMedID- 20645852 The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome.
PubMedID- 25661453 We aimed to determine the association between the quantity of liver fat and the presence of the metabolic syndrome in patients with biopsy-proven nonalcoholic fatty liver disease (nafld), independent of nonalcoholic steatohepatitis (nash).

Page: 1